Domenici et al (2010) reported elevated plasma levels of MMP‐9 and its endogenous inhibitor, tissue inhibitor of matrix metalloproteinases (TIMP‐1), in schizophrenia patients (also see Chang et al, 2011; Yamamori et al, 2013). The gene discussed is MMP9; the disease is schizophrenia.